Stefan Holdenrieder Selected Research

HMGB1 Protein (HMG1)

10/2023	Immunogenic Biomarkers HMGB1 and sRAGE Are Potential Diagnostic Tools for Ovarian Malignancies.
7/2021	Relevance of Circulating Nucleosomes, HMGB1 and sRAGE for Prostate Cancer Diagnosis.
2/2021	Soluble High Mobility Group Box 1 (HMGB1) Is a Promising Biomarker for Prediction of Therapy Response and Prognosis in Advanced Lung Cancer Patients.
1/2020	Time courses of HMGB1 and other inflammatory markers after generalized convulsive seizures.
1/2016	Paradoxical Role of HMGB1 in Pancreatic Cancer: Tumor Suppressor or Tumor Promoter?
6/2015	Circulating HMGB1 and RAGE as Clinical Biomarkers in Malignant and Autoimmune Diseases.
12/2013	Circulating nucleosomes and immunogenic cell death markers HMGB1, sRAGE and DNAse in patients with advanced pancreatic cancer undergoing chemotherapy.
5/2013	Immunogenic cell death biomarkers HMGB1, RAGE, and DNAse indicate response to radioembolization therapy and prognosis in colorectal cancer patients.
2/2013	Circulating immunogenic cell death biomarkers HMGB1 and RAGE in breast cancer patients during neoadjuvant chemotherapy.
12/2012	Predictive value of immunogenic cell death biomarkers HMGB1, sRAGE, and DNase in liver cancer patients receiving transarterial chemoembolization therapy.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Stefan Holdenrieder Research Topics

Disease

90	Neoplasms (Cancer) 05/2024 - 09/2004
19	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2024 - 09/2004
18	Colorectal Neoplasms (Colorectal Cancer) 06/2022 - 05/2005
17	Pancreatic Neoplasms (Pancreatic Cancer) 08/2022 - 01/2005
16	Lung Neoplasms (Lung Cancer) 01/2024 - 09/2004
14	Breast Neoplasms (Breast Cancer) 03/2024 - 01/2008
10	Neoplasm Metastasis (Metastasis) 08/2023 - 08/2008
10	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 10/2010
7	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 10/2023 - 01/2003
6	Inflammation (Inflammations) 10/2023 - 05/2013
6	Disease Progression 10/2023 - 09/2006
6	Acute Coronary Syndrome 01/2023 - 10/2017
6	Stroke (Strokes) 01/2023 - 09/2004
5	Wounds and Injuries (Trauma) 03/2023 - 01/2009
5	Congenital Diaphragmatic Hernias 01/2023 - 07/2018
4	Lung Diseases (Lung Disease) 01/2024 - 05/2010
4	Hemorrhage 08/2023 - 01/2019
4	Myocardial Infarction 01/2023 - 08/2010
4	Necrosis 08/2022 - 06/2015
4	Renal Cell Carcinoma (Grawitz Tumor) 12/2021 - 01/2011
4	Autoimmune Diseases (Autoimmune Disease) 06/2015 - 09/2006
4	Urinary Bladder Neoplasms (Bladder Cancer) 01/2015 - 01/2003
4	Liver Neoplasms (Liver Cancer) 01/2013 - 05/2011
3	Heart Failure 11/2023 - 01/2020
3	Ovarian Neoplasms (Ovarian Cancer) 10/2023 - 01/2008
3	Breast Diseases (Breast Disease) 09/2023 - 02/2013
3	COVID-19 09/2023 - 01/2021
3	Myocardial Ischemia (Ischemic Heart Diseases) 08/2022 - 11/2020
3	Liver Diseases (Liver Disease) 12/2014 - 03/2009
3	Acute Disease 05/2012 - 05/2010
3	Sepsis (Septicemia) 05/2012 - 01/2009
2	Congenital Heart Defects (Congenital Heart Defect) 10/2023 - 11/2021
2	Thrombosis (Thrombus) 09/2023 - 08/2010
2	Carcinogenesis 08/2023 - 05/2014
2	Melanoma (Melanoma, Malignant) 01/2023 - 02/2021
2	Pulmonary Hypertension 01/2023 - 07/2018
2	Bone Neoplasms (Bone Cancer) 08/2022 - 04/2020
2	Circulating Neoplastic Cells 06/2022 - 04/2016
2	Drug-Related Side Effects and Adverse Reactions 12/2021 - 04/2016

Drug/Important Bio-Agent (IBA)

82	Biomarkers (Surrogate Marker)IBA 03/2024 - 09/2004
30	Nucleosomes (Nucleosome)IBA 07/2021 - 09/2004
26	Tumor Biomarkers (Tumor Markers)IBA 03/2024 - 01/2003
24	DNA (Deoxyribonucleic Acid)IBA 12/2022 - 09/2004
22	AntigensIBA 11/2023 - 01/2006
20	Cell-Free Nucleic AcidsIBA 03/2024 - 10/2010
16	Proteins (Proteins, Gene)FDA Link 01/2024 - 01/2003
12	Carcinoembryonic AntigenIBA 01/2024 - 09/2006
11	HMGB1 Protein (HMG1)IBA 10/2023 - 06/2012
11	MicroRNAs (MicroRNA)IBA 06/2022 - 01/2011
10	antigen CYFRA21.1IBA 01/2024 - 01/2006
9	LigandsIBA 01/2024 - 12/2006
9	Histones (Histone)IBA 01/2021 - 05/2010
8	Phosphopyruvate Hydratase (Enolase)IBA 01/2024 - 01/2003
8	pro-gastrin-releasing peptide (31-98)IBA 10/2023 - 09/2006
7	CarbohydratesIBA 01/2023 - 01/2006
7	Deoxyribonucleases (DNase)FDA Link 12/2014 - 06/2012
6	big gastrinIBA 09/2020 - 09/2006
6	Peptides (Polypeptides)IBA 09/2020 - 09/2006
5	pro-brain natriuretic peptide (1-76)IBA 03/2024 - 01/2020
5	Prostate-Specific Antigen (Semenogelase)IBA 01/2024 - 09/2013
5	CytokinesIBA 08/2023 - 09/2015
5	alpha-Fetoproteins (alpha-Fetoprotein)IBA 06/2023 - 12/2014
5	RNA (Ribonucleic Acid)IBA 06/2022 - 11/2012
4	C-Reactive ProteinIBA 11/2023 - 09/2006
4	EnzymesIBA 10/2023 - 01/2003
4	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2022 - 10/2015
4	Keratin-19 (Keratin 19)IBA 04/2017 - 09/2006
4	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2015 - 05/2006
3	Complement System Proteins (Complement)IBA 05/2024 - 01/2022
3	Circulating Tumor DNAIBA 01/2024 - 12/2019
3	Immune Checkpoint InhibitorsIBA 01/2024 - 11/2016
3	Advanced Glycation End ProductsIBA 10/2023 - 05/2012
3	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 09/2023 - 12/2014
3	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 09/2023 - 01/2016
3	Macrophage Migration-Inhibitory FactorsIBA 08/2023 - 05/2012
3	CholesterolIBA 11/2018 - 09/2004
3	Interleukin-8 (Interleukin 8)IBA 01/2017 - 12/2014
3	Keratins (Keratin)IBA 01/2016 - 05/2005
3	AutoantibodiesIBA 01/2014 - 09/2006
3	micaIBA 07/2007 - 02/2006
2	Fetal Proteins (Fetoprotein)IBA 01/2024 - 01/2015
2	ChemokinesIBA 09/2023 - 01/2016
2	Glycoproteins (Glycoprotein)IBA 08/2023 - 06/2023
2	Prasugrel Hydrochloride FDA Link 01/2023 - 01/2022
2	TicagrelorIBA 01/2023 - 01/2022
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 10/2022 - 11/2020
2	Alanine Transaminase (SGPT)IBA 10/2022 - 09/2019
2	Alkaline PhosphataseIBA 08/2022 - 10/2017
2	ElementsIBA 06/2022 - 03/2021
2	Oxygen (Dioxygen)IBA 12/2021 - 10/2017

Therapy/Procedure

44	Therapeutics 01/2024 - 01/2006
23	Drug Therapy (Chemotherapy) 01/2024 - 09/2004
7	Radiotherapy 01/2023 - 09/2004
5	Neoadjuvant Therapy 10/2013 - 05/2012
4	Immunotherapy 05/2023 - 11/2016
2	Transcatheter Aortic Valve Replacement 11/2023 - 05/2018
2	Patient Readmission 11/2023 - 10/2015
2	Percutaneous Coronary Intervention 08/2023 - 01/2021
2	Artificial Respiration (Mechanical Ventilation) 01/2023 - 12/2021
2	Castration 01/2022 - 01/2020